[go: up one dir, main page]

FI924642L - Menetelmä terapeuttisesti aktiivisten 3-indolyylitioasetaattijohdannaisten valmistamiseksi - Google Patents

Menetelmä terapeuttisesti aktiivisten 3-indolyylitioasetaattijohdannaisten valmistamiseksi Download PDF

Info

Publication number
FI924642L
FI924642L FI924642A FI924642A FI924642L FI 924642 L FI924642 L FI 924642L FI 924642 A FI924642 A FI 924642A FI 924642 A FI924642 A FI 924642A FI 924642 L FI924642 L FI 924642L
Authority
FI
Finland
Prior art keywords
indolylthioacetate
derivatives
preparation
therapeutically active
therapeutically
Prior art date
Application number
FI924642A
Other languages
English (en)
Swedish (sv)
Other versions
FI98454B (fi
FI98454C (fi
FI924642A0 (fi
Inventor
Francesco G Salituro
Bruce M Baron
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of FI924642L publication Critical patent/FI924642L/fi
Publication of FI924642A0 publication Critical patent/FI924642A0/fi
Publication of FI98454B publication Critical patent/FI98454B/fi
Application granted granted Critical
Publication of FI98454C publication Critical patent/FI98454C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Lubricants (AREA)
  • Hard Magnetic Materials (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI924642A 1990-04-25 1992-10-14 Menetelmä terapeuttisesti aktiivisten 3-indolyylitioasetaattijohdannaisten valmistamiseksi FI98454C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US07/514,074 US5051442A (en) 1990-04-25 1990-04-25 3-indolyl thioacetate derivatives and NMDA receptor antagonistic use thereof
US51407490 1990-04-25
US9102179 1991-03-28
PCT/US1991/002179 WO1991016307A1 (en) 1990-04-25 1991-03-28 3-indolyl thioacetate derivatives

Publications (4)

Publication Number Publication Date
FI924642L true FI924642L (fi) 1992-10-14
FI924642A0 FI924642A0 (fi) 1992-10-14
FI98454B FI98454B (fi) 1997-03-14
FI98454C FI98454C (fi) 1997-06-25

Family

ID=24045696

Family Applications (1)

Application Number Title Priority Date Filing Date
FI924642A FI98454C (fi) 1990-04-25 1992-10-14 Menetelmä terapeuttisesti aktiivisten 3-indolyylitioasetaattijohdannaisten valmistamiseksi

Country Status (14)

Country Link
US (1) US5051442A (fi)
EP (1) EP0526478B1 (fi)
JP (1) JP3006881B2 (fi)
KR (1) KR0178281B1 (fi)
AT (1) ATE119882T1 (fi)
AU (1) AU646251B2 (fi)
CA (1) CA2081330C (fi)
DE (1) DE69108234T2 (fi)
DK (1) DK0526478T3 (fi)
ES (1) ES2072607T3 (fi)
FI (1) FI98454C (fi)
HU (1) HU213205B (fi)
NO (1) NO178857C (fi)
WO (1) WO1991016307A1 (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5189054A (en) * 1990-11-02 1993-02-23 Merrell Dow Pharmaceuticals Inc. 3-amidoindolyl derivatives and pharmaceutical compositions thereof
US5318985A (en) * 1991-12-20 1994-06-07 Merrell Dow Pharmaceuticals Inc. Potentiation of NMDA antagonists
US5321012A (en) * 1993-01-28 1994-06-14 Virginia Commonwealth University Medical College Inhibiting the development of tolerance to and/or dependence on a narcotic addictive substance
USRE39300E1 (en) 1993-01-28 2006-09-19 Virginia Commonwealth University Medical College Of Virginia Inhibiting the development of tolerance to and/or dependence on an addictive substance
GB9311948D0 (en) * 1993-06-10 1993-07-28 Zeneca Ltd Substituted nitrogen heterocycles
US5424329A (en) * 1993-08-18 1995-06-13 Warner-Lambert Company Indole-2-carboxamides as inhibitors of cell adhesion
US5801168A (en) * 1994-06-09 1998-09-01 Zeneca Limited Substituted nitrogen heterocycles
ATE206701T1 (de) * 1996-04-19 2001-10-15 American Home Prod Östrogene verbindungen
US6069153A (en) * 1998-05-12 2000-05-30 American Home Products Corporation Indenoindoles and benzocarbazoles as estrogenic agents
US6479535B1 (en) 1998-05-15 2002-11-12 Wyeth 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations
US6159959A (en) * 1999-05-06 2000-12-12 American Home Products Corporation Combined estrogen and antiestrogen therapy
AR081930A1 (es) 2010-06-16 2012-10-31 Ardea Biosciences Inc Compuestos de tioacetato
EP2582664A4 (en) 2010-06-16 2014-07-09 Ardea Biosciences Inc PHENYL THIOACETATE COMPOUNDS AND COMPOSITIONS AND METHOD FOR THEIR USE
CN106963761A (zh) 2011-11-03 2017-07-21 阿迪亚生命科学公司 3,4‑二取代的吡啶化合物、其使用方法以及包含该化合物的组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675332A (en) * 1984-12-10 1987-06-23 Warner-Lambert Company Acidic tetrazolyl substituted indole compounds and their use as antiallergy agents
IL84796A (en) * 1986-12-17 1992-03-29 Merck Frosst Canada Inc Substituted n-benzyl-indoles and pharmaceutical compositions containing them
US4960786A (en) * 1989-04-24 1990-10-02 Merrell Dow Pharmaceuticals Inc. Excitatory amino acid antagonists
JPH0347123A (ja) * 1989-05-05 1991-02-28 G D Searle & Co インドール―２―カルボキシレート化合物類を含有するｃｎｓ疾患治療用組成物

Also Published As

Publication number Publication date
CA2081330A1 (en) 1991-10-26
FI98454B (fi) 1997-03-14
DE69108234D1 (en) 1995-04-20
HU213205B (en) 1997-03-28
ATE119882T1 (de) 1995-04-15
DE69108234T2 (de) 1995-08-24
DK0526478T3 (da) 1995-05-29
WO1991016307A1 (en) 1991-10-31
JPH07500567A (ja) 1995-01-19
EP0526478A1 (en) 1993-02-10
NO924126L (no) 1992-10-23
CA2081330C (en) 2002-02-05
AU7650091A (en) 1991-11-11
KR937000438A (ko) 1993-03-15
NO178857C (no) 1996-06-19
JP3006881B2 (ja) 2000-02-07
US5051442A (en) 1991-09-24
FI98454C (fi) 1997-06-25
ES2072607T3 (es) 1995-07-16
HUT64744A (en) 1994-02-28
HU9203336D0 (en) 1993-01-28
KR0178281B1 (ko) 1999-03-20
AU646251B2 (en) 1994-02-17
NO924126D0 (no) 1992-10-23
FI924642A0 (fi) 1992-10-14
NO178857B (no) 1996-03-11
EP0526478B1 (en) 1995-03-15

Similar Documents

Publication Publication Date Title
FI883050L (fi) Menetelmä terapeuttisesti aktiivisten pyranoindolitsinokinoliinijohdannaisten valmistamiseksi
FI92934B (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 1-deoksinojirimysiinijohdannaisten valmistamiseksi
NO179448C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive forbindelser
NO179283C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte azoler
FI890282L (fi) Menetelmä terapeuttisesti käyttökelpoisten 23,24-didehydro-25-hydroksikalsiferolijohdannaisten valmistamiseksi
FI873205A0 (fi) Menetelmä terapeuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi
FI890652A (fi) Menetelmä terapeuttisesti aktiivisten substituoitujen indolyylipyrrolijohdannaisten valmistamiseksi
FI892497L (fi) Menetelmä terapeuttisesti aktiivisten bentsamidijohdannaisten valmistamiseksi
FI923527L (fi) Menetelmä terapeuttisesti käyttökelpoisten 3-piperidino-4-hydroksikromaanijohdannaisten valmistamiseksi
FI930723L (fi) Menetelmä terapeuttisesti aktiivisten tiatsolidiinijohdannaisten valmistamiseksi
NO175528C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive fenylacetamid-derivater
FI880869A (fi) Menetelmä terapeuttisesti aktiivisten tetratsolijohdannaisten valmistamiseksi
FI925871L (fi) Menetelmä terapeuttisesti aktiivisten fenyyliguanidiinijohdannaisten valmistamiseksi
FI921473L (fi) Menetelmä terapeuttisesti käyttökelpoisten bentsimidatsolijohdannaisten valmistamiseksi
FI906408L (fi) Menetelmä terapeuttisesti käyttökelpoisten 2-aminopyrimidiini-4-karboksamidijohdannaisten valmistamiseksi
NO173334C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive alkylaminoalkylenderivater 2H-1-benzopyraner
FI924642L (fi) Menetelmä terapeuttisesti aktiivisten 3-indolyylitioasetaattijohdannaisten valmistamiseksi
FI93215C (fi) Menetelmä terapeuttisesti käyttökelpoisten aminoalkoksifenyylijohdannaisten valmistamiseksi
FI104075B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten 2-karboksitienyylikarbamoyylipyrrolidin-4-yylitiokarbapeneemi-3-karboksyylihappojohdannaisten valmistamiseksi
FI893003L (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten neplanosiinijohdannaisten valmistamiseksi
FI882002L (fi) Menetelmä terapeuttisesti aktiivisten fenyylipiperidiinijohdannaisten valmistamiseksi
FI98461B (fi) Menetelmä terapeuttisesti käyttökelpoisten yhdisteiden valmistamiseksi
FI903077A0 (fi) Menetelmä valmistaa terapeuttisesti aktiivisia R(-)-3-kinuklidinolijohdannaisia
FI911747L (fi) Menetelmä terapeuttisesti aktiivisten substituoitujen aromaattisten sulfonamidijohdannaisten valmistamiseksi
FI100799B (fi) Menetelmä terapeuttisesti aktiivisten tetraliinijohdannaisten valmista miseksi

Legal Events

Date Code Title Description
BB Publication of examined application